Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals (TLPPF), Medline (MDLN)

Tipranks - Tipranks - Fri Apr 17, 1:26AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Telix Pharmaceuticals (TLPPF) and Medline (MDLN) with bullish sentiments.

Claim 30% Off TipRanks

Telix Pharmaceuticals (TLPPF)

RBC Capital analyst Craig Wong-Pan maintained a Buy rating on Telix Pharmaceuticals yesterday and set a price target of A$18.00. The company’s shares closed last Wednesday at $10.50, close to its 52-week low of $8.14.

According to TipRanks.com, Wong-Pan is a 1-star analyst with an average return of -1.4% and a 47.4% success rate. Wong-Pan covers the Healthcare sector, focusing on stocks such as Nanosonics Limited, Ramsay Health Care, and Cochlear. ;'>

Telix Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $17.85, representing a 78.5% upside. In a report issued on April 7, Bell Potter also maintained a Buy rating on the stock with a A$19.00 price target.

See today’s best-performing stocks on TipRanks >>

Medline (MDLN)

In a report released yesterday, Ryan Halsted from RBC Capital maintained a Buy rating on Medline, with a price target of $53.00. The company’s shares closed last Wednesday at $47.93.

According to TipRanks.com, Halsted is a 1-star analyst with an average return of -9.2% and a 32.0% success rate. Halsted covers the Healthcare sector, focusing on stocks such as Privia Health Group, Healthcare Services, and Charles River Labs. ;'>

Medline has an analyst consensus of Strong Buy, with a price target consensus of $53.71, representing a 13.0% upside. In a report issued on March 31, TipRanks – PerPlexity also initiated coverage with a Buy rating on the stock with a $49.00 price target.

Read More on TLPPF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).